E
Edward L. Spitznagel
Researcher at Washington University in St. Louis
Publications - 275
Citations - 26688
Edward L. Spitznagel is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Substance abuse & Population. The author has an hindex of 79, co-authored 275 publications receiving 25310 citations. Previous affiliations of Edward L. Spitznagel include Florida State University College of Arts and Sciences & Barnes-Jewish Hospital.
Papers
More filters
Journal ArticleDOI
ASA Physical Status Classifications: A Study of Consistency of Ratings
TL;DR: The ASA Physical Status Classification is useful but suffers from a lack of scientific precision.
Journal ArticleDOI
Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database
Ramaswamy Govindan,Nathan C. Page,Daniel Morgensztern,William L. Read,Ryan M. Tierney,Anna Vlahiotis,Edward L. Spitznagel,Jay F. Piccirillo +7 more
TL;DR: The analysis indicates that the incidence of SCLC is decreasing in the United States, and only modest improvements have been seen in survival over the last 30 years.
Journal ArticleDOI
Prognostic importance of comorbidity in a hospital-based cancer registry
TL;DR: Comorbidity is an important independent prognostic factor for patients with cancer and the inclusion of comorbidities in hospital-based cancer registries will increase the value and use of observational research.
Journal ArticleDOI
Psychiatric disorders among survivors of the Oklahoma City bombing.
Carol S. North,Sara Jo Nixon,Sheryll Shariat,Sue Mallonee,J. Curtis McMillen,Edward L. Spitznagel,Elizabeth M. Smith +6 more
TL;DR: The data suggest that a focus on avoidance and numbing symptoms could have provided an effective screening procedure for PTSD and could have identified most psychiatric cases early in the acute postdisaster period.
Journal ArticleDOI
The effect of prescribed daily dose frequency on patient medication compliance.
TL;DR: Compliance improves dramatically as prescribed dose frequency decreases, and probably the single most important action that health care providers can take to improve compliance is to select medications that permit the lowest daily prescribe dose frequency.